In particular, the activation of the NRF2‒HO-1 axis is now proposed to be a candidate to treat COVID-19 patients [46,47,48], and A. lavenia extract has been shown to ameliorate the pathogenesis of a model pneumonia induced by lipopolysaccharides [2]. Here, NFE2L2 is linked to COVID-19.